PAMCX
Price
$96.40
Change
+$0.36 (+0.37%)
Updated
Jan 17 closing price
Net Assets
30.69B
TEGAX
Price
$39.46
Change
+$0.17 (+0.43%)
Updated
Jan 17 closing price
Net Assets
1.43B
Ad is loading...

PAMCX vs TEGAX

Header iconPAMCX vs TEGAX Comparison
Open Charts PAMCX vs TEGAXBanner chart's image
T. Rowe Price Mid-Cap Growth Adv
Price$96.40
Change+$0.36 (+0.37%)
VolumeN/A
Net Assets30.69B
Touchstone Mid Cap Growth A
Price$39.46
Change+$0.17 (+0.43%)
VolumeN/A
Net Assets1.43B
PAMCX vs TEGAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PAMCX vs. TEGAX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAMCX is a Hold and TEGAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 30.7B vs. TEGAX (1.43B). PAMCX (0.00) and TEGAX (0.00) have matching dividends . PAMCX was incepted earlier than TEGAX: PAMCX (25 years) vs TEGAX (30 years). TEGAX is a more actively managed with annual turnover of: 56.00 vs. PAMCX (21.70). PAMCX (2500) and TEGAX (2500) have matching initial minimum investment requirements. TEGAX annual gain was more profitable for investors over the last year : 18.78 vs. PAMCX (2.30). TEGAX return over 5 years is better than : 17.72 vs. PAMCX (1.44).
PAMCXTEGAXPAMCX / TEGAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence25 years30 years-
Gain YTD2.5974.22661%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets30.7B1.43B2,150%
Annual Yield % from dividends0.000.00-
Returns for 1 year2.3018.7812%
Returns for 3 years-5.1616.13-32%
Returns for 5 years1.4417.728%
Returns for 10 years33.0057.6957%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRTS3.910.01
+0.26%
Alpha Tau Medical Ltd
MFA10.100.02
+0.20%
MFA Financial
LSTA3.71-0.01
-0.27%
Lisata Therapeutics
EFX262.87-1.37
-0.52%
Equifax
AXSM91.93-1.75
-1.87%
Axsome Therapeutics